Page 42 - Intramural Research Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Obesity drives risk for COVID-19 among Latino patients with rheumatic disease ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS You've successfully added to your alerts. You will receive an email when new content is published. Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Latino p...

By Rich McManus NIAID’s Dr. Helen Su When the global pandemic caused by a novel coronavirus made its debut in late 2019, NIAID’s Dr. Helen Su was studying inborn errors of immunity in patients with viral infections, mostly rhinoviruses, which cause colds, and influenza. Why, she wondered, was there such variability of outcomes in people infected with the same virus? In a remarkable example of the NIH Intramural Research Program’s nimbleness, she and her colleagues quickly pivoted to studies of SARS-CoV-2 when it became apparent that Covid-19, the disease caused by the virus, was spreadi...

Harmful and Healing Responses to Brain Injury Diverge by Cellular Mediators and Time January 20, 2021 Harmful and healing immune responses to cerebrovascular injury depend on the timing of the response and cells mediating the response, a new study reports. Injury to blood vessels in the brain, or cerebrovascular injury, commonly caused by a stroke that blocks a blood vessel (ischemic stroke), can result in severe swelling and inflammation. In patients with short-term blockade of a blood vessel in the brain removing a blood clot from the lumen of a prominent blood vessel to restore blood flow,...

Researchers from the National Institutes of Health have discovered Jekyll and Hyde immune cells in the brain that ultimately help with brain repair but...

Dr. Neil Hanchard joins NHGRI as a clinical investigator SHARE: Dr. Hanchard will lead the new Childhood Complex Disease Genomics Section. The National Human Genome Research Institute (NHGRI) has appointed Neil Hanchard, M.D., Ph.D., as a clinical investigator within the Medical Genomics and Metabolic Genetics Branch (MGMGB) in the NHGRI Division of Intramural Research. Dr. Hanchard will head the Childhood Complex Disease Genomics Section within the MGMGB. “We are delighted to welcome Neil Hanchard to the NHGRI Intramural Research Program,” said Dan Kastner, M.D., Ph.D., NHGRI's scientifi...